Varex Imaging (VREX) Total Non-Current Liabilities (2016 - 2026)
Varex Imaging (VREX) posted quarterly Total Non-Current Liabilities of $553.1 million for Q2 2026, down 26.66% year-over-year from $754.2 million in Q2 2025, and down 0.88% quarter-over-quarter from $558.0 million in Q1 2026.
Varex Imaging (VREX) Total Non-Current Liabilities (2016 - 2026) Analysis & Trends
Varex Imaging (VREX) has reported Total Non-Current Liabilities for 11 consecutive years, with $553.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Non-Current Liabilities fell 26.66% year-over-year to $553.1 million; the TTM figure through Apr 2026 stood at $553.1 million (down 26.66% YoY), while the FY2025 annual figure was $582.7 million, down 6.02% from the prior year.
- Total Non-Current Liabilities retreated to $553.1 million in Q2 2026 per VREX's latest filing, from $558.0 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $754.2 million in Q2 2025 and bottomed at $553.1 million in Q2 2026.
- Historically, Total Non-Current Liabilities has averaged $617.7 million across 5 years, with a median of $614.4 million in 2023.
- Annual changes were most pronounced in 2025 — Total Non-Current Liabilities gained 21.76% — and 2026, when it retreated 26.66%.
- Varex Imaging's Total Non-Current Liabilities stood at $616.1 million in 2022, then declined by 0.28% to $614.4 million in 2023, then advanced by 0.91% to $620.0 million in 2024, then retreated by 6.02% to $582.7 million in 2025, then fell by 5.08% to $553.1 million in 2026.
- Business Quant data shows VREX's Total Non-Current Liabilities at $553.1 million in Q2 2026, $558.0 million in Q1 2026, and $582.7 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.77 Bn | 123.30 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 73.18 Bn | 72.64 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 52.05 Bn | 47.80 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.35 Bn | 32.40 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Varex Imaging | 778.01 Mn | 678.81 Mn | 76.70 Mn | 542.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 542.80 Mn |
| Apr 3, 2026 | 553.10 Mn |
| Jan 2, 2026 | 558.00 Mn |
| Oct 3, 2025 | 582.70 Mn |
| Jul 4, 2025 | 564.70 Mn |
| Apr 4, 2025 | 754.20 Mn |
| Jan 3, 2025 | 737.50 Mn |
| Sep 27, 2024 | 620.00 Mn |
| Jun 28, 2024 | 614.30 Mn |
| Mar 29, 2024 | 619.40 Mn |
| Dec 29, 2023 | 614.40 Mn |
| Sep 29, 2023 | 627.00 Mn |
| Jun 30, 2023 | 623.10 Mn |
| Mar 31, 2023 | 615.30 Mn |
| Dec 30, 2022 | 616.10 Mn |
| Sep 30, 2022 | 603.90 Mn |
| Jul 1, 2022 | 602.60 Mn |
| Apr 1, 2022 | 594.50 Mn |
| Dec 31, 2021 | 600.90 Mn |
| Oct 1, 2021 | 619.20 Mn |